Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)Nizar M. Tannir, Oleg Karyakin, Maria Nirvana Formiga et al.|Journal of Clinical Oncology|2024Cited by 26
The Evolving Role of Biomarkers in Personalized Lung Cancer TherapyJanaki Sharma, Balázs Halmos, Haiying Cheng et al.|Respiration|2016Cited by 11